x

Search for a networks

* (*) mandatory field

A Phase Ib/II Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission

  • Type of network : Multinational clinical trials
  • Funded by an IRDiRC member
  • Geographic coverage : Global
  • Funding body(ies) : HOFFMANN - LA ROCHE LTD. 
  • Sponsor : Information not provided
  • Website
  • Coordinator of multinational clinical trial

  • INFORMATION NOT PROVIDED
  • Institution: Information not provided - CH
  • ADDRESS: NOT PROVIDED - CH
  • SWITZERLAND
  • More information
  • Phone  : -
  • Fax  : -
Last update: May 2019

Participants

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.